Skip to main content

Table 1 Risk factors, biological data and medications according to FP and DE scores: n (%) or median (25th and 75th percentile)

From: Utility of Cardiac Magnetic Resonance to assess association between admission hyperglycemia and myocardial damage in patients with reperfused ST-Segment Elevation Myocardial Infarction

 

FP score ≤ median (n = 57)

FP score > median (n = 56)

p

DE score ≤ median (n = 57)

DE score > median (n = 56)

p

Risk factors

      

Age (years)

56 (48–69)

56 (49–68)

0.66

56 (51–68)

57 (48–68)

0.98

Male

43 (75)

48 (86)

0.25

44 (77)

47 (84)

0.51

BMI (kg/m2)

25 (24–28)

26 (24–28)

0.35

25 (24–29)

25 (24–28)

0.54

Hypertension

25 (44)

16 (29)

0.14

22 (39)

19 (34)

0.75

Diabetes

5 (9)

7 (12)

0.74

6 (11)

6 (11)

0.79

Hypercholesterolemia

19 (33)

23 (41)

0.51

23 (40)

19 (34)

0.61

Smoking

23 (40)

29 (52)

0.30

22 (39)

30 (54)

0.42

Previous PCI or CABG

2 (4)

2 (4)

1.00

3 (5)

1 (2)

0.62

Peripheral arterial disease

2 (4)

2 (4)

1.00

2 (4)

2 (4)

1.00

Biological data

      

Hyperglycemia (≥ 7.8 mmol/l)

17 (30)

35 (63)

<0.001

16 (28)

36 (64)

<0.001

Glycemia (mmol/l)

7.0 (6.1–8.4)

8.4 (6.9–9.7)

0.001

6.9 (5.9–8.2)

8.4 (7.0–9.6)

<0.001

HbA1c (%)

5.4 (5.2–5.7)

5.7 (5.4–6.3)

0.01

5.5 (5.2–5.7)

5.7 (5.4–6.3)

0.04

Peak CK >10 fold UNL

21 (37)

45 (80)

<0.001

17 (30)

49 (88)

<0.001

CRP (mg/l)

2.2 (1.7–10.0)

4.6 (2.0–11.0)

0.48

2.5 (2.0–11.0)

4.7 (2.0–9.0)

0.81

Creatinine clearance (ml/mn)

87 (73–116)

92 (75–111)

0.48

92 (74–117)

88 (72–111)

0.77

HDL-Cholesterol (mmol/l)

1.04 (0.91–1.33)

1.17 (0.96–1.41)

0.15

1.08 (0.91–1.33)

1.17 (0.94–1.34)

0.50

LDL-Cholesterol (mmol/l)

2.99 (2.49–3.73)

3.01 (2.49–3.90)

0.74

2.93 (2.47–3.79)

3.19 (2.56–3.84)

0.54

Triglyceride (mmol/l)

1.42 (0.92–2.5)

1.29 (0.97–1.73)

0.22

1.45 (1.01–2.4)

1.26 (0.90–1.79)

0.08

Current treatment

      

Statin

6 (11)

8 (14)

0.75

6 (11)

8 (14)

0.75

Insulin

1 (2)

0 (0)

0.99

1 (2)

0 (0)

0.99

ACE inhibitor

6 (11)

3 (5)

0.51

3 (5)

6 (11)

0.47

Beta Blocker

10 (18)

6 (11)

0.44

9 (16)

7 (13)

0.82

Oral antidiabetic

2 (4)

4 (7)

0.66

2 (4)

4 (7)

0.66

Acute medications

      

Gp IIb/IIIa receptor blocker

30 (53)

23 (41)

0.30

24 (42)

29 (52)

0.40

Antiplatelet

48 (84)

52 (93)

0.25

48 (84)

52 (93)

0.25

  1. ACE = Angiotensin-Converting Enzyme; BMI = Body Mass Index; CABG = Coronary Artery Bypass Graft; CK = Creatine Kinase; CRP = C-Reactive Protein; PCI = Percutaneous Coronary Intervention; SBP = Systolic Blood Pressure; UNL = Upper Normal Limit.
Back to article page

Journal of Cardiovascular Magnetic Resonance

ISSN: 1532-429X

Contact us